TABLE 4.
Selected 3D viral hepatitis models established from different cell types.
| Cell type | Culture paradigm | Culture period | Endpoints | Application | References |
|---|---|---|---|---|---|
| PHHs | MPCC co-culture | 21 days | Expression of NTCP receptors | Disease modeling: HBV infection | Shlomai et al. (2014) |
| Expression of HBsAg and HBcAg | |||||
| Expression of HBV DNA and replication intermediates | |||||
| Induced ISG gene expression | |||||
| PHHs | Liver-on-a-chip mono-culture | 22 days | Expression of HBsAg and HBcAg | Disease modeling: HBV infection | Ortega-Prieto et al. (2018) |
| Expression of HBV DNA and replication intermediates | |||||
| Suppressed baseline innate immune activation | |||||
| Similar chemokine and cytokine responses as seen in HBV-infected patients | |||||
| hiPSC-HLCs | Organoid co-culture | 42 days | Expression of NTCP receptors | Disease modeling: HBV infection | Nie et al. (2018) |
| Expression of HBV DNA and replication intermediates | |||||
| Expression of HBcAg and known infection-promoting factors | |||||
| Viral dose-dependent hepatic dysfunction |
PHHs, primary human hepatocytes; hiPSCs, human induced pluripotent stem cells; HLCs, hepatocyte-like cells; NTCP, sodium-taurocholate co-transporting polypeptide; ISG, interferon-stimulated gene; MPCC, micropatterned co-culture; HBcAg, HBV core antigen.